In humans, apolipoprotein E (apoE) has three major isoforms, E2 (Cys(1
12), Cys(158)), E3 (Cys(112), Arg(158)), and E4 (Arg(112), Arg(158)).
While epsilon 4 is a genetic risk factor for Alzheimer's disease (AD),
epsilon 2 may protect against late-onset AD. Using native preparation
s of apoE from conditioned tissue culture media or plasma lipoproteins
, we have previously shown that when equivalent amounts of apoE3 or E4
were incubated with beta-amyloid (A beta), apoE3 formed 20 times as m
uch SDS-stable complex with the peptide as apoE4. This preferential bi
nding of A beta to apoE3 was abolished-when apoE was purified by a pro
cess which includes delipidation and denaturation. Here we expand thes
e observations to include A beta binding to lipoprotein-associated and
purified apoE2. Lipoproteins isolated from the plasma of individuals
homozygous for either epsilon 2 or epsilon 3 were incubated with A bet
a(1-40). SDS-stable complex formation was analysed by a non-reducing g
el shift assay, followed by immunoblotting with either A beta or apoE
antibodies. ApoE2:A beta complex formation was comparable to apoE3:A b
eta in both native and purified preparations of apoE. In addition, lip
oprotein-associated rat apoE (Arg(112), Arg(158)), like human apoE4, d
id not form complex with A beta, while lipoprotein-associated rabbit a
poE (Cys(112), Arg(158)) did bind the peptide. These binding studies p
rovide one possible explanation for protective effects of both apoE2 a
nd E3 against the development of Alzheimer's disease. (C) 1997 Wiley-L
iss, Inc.